My perspective comes from having worked across the full drug development journey.

For nearly two decades, I have lived and worked between Poland and Germany.
The same has been true throughout my career. My background spans science and business, from biotechnology and a doctorate in life sciences to an MBA. My work has taken me from preclinical research and early clinical development through due diligence to leading global late development programs.
Over the years, I developed a deep understanding of different perspectives. Scientific and commercial. Strategic and operational. Local and global.
Having led programs myself, I learned that success rarely comes from a single breakthrough. It is the result of many good decisions made along the way.
Today, I work with biotech and pharmaceutical companies navigating complex development programs. Because every program is shaped by the quality of the decisions made throughout its journey.


- Experience
- 15+ years
- Preclinical → Translational → Phase I–III
- Regions
- Americas · EMEA · APAC
- Languages
- EN · DE · PL
Let's talk about your program.
Whether you're scoping a new global trial, recovering a delayed program, or evaluating an external asset — start with a conversation.
